Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

2.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.9K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

1.7K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.7K
Insensitive Nuclei Enhanced by Polarization Transfer (INEPT)01:15

Insensitive Nuclei Enhanced by Polarization Transfer (INEPT)

1.1K
Insensitive Nuclei Enhanced by Polarization Transfer (INEPT) is an advanced Nuclear Magnetic Resonance (NMR) technique specifically designed to detect and enhance the signals of low-abundance nuclei, such as carbon-13 and nitrogen-15, in small molecules. The fundamental principle behind INEPT is the transfer of polarization from a more abundant and highly polarizable nucleus, typically hydrogen-1, to the low-abundance nucleus of interest. This process effectively boosts the NMR signal of the...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Making Artificial Intelligence More Intelligent and Less Artificial for Rheumatology: A Vision for Empathy, Education, Equity, and Ethics.

Arthritis care & research·2026
Same author

The influence of nuclear antigen form on complement activation by systemic lupus erythematosus antinuclear antibody immune complexes determined by a novel immunocapture assay.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Reply.

Arthritis & rheumatology (Hoboken, N.J.)·2025
Same author

Z-GENIE: a user-friendly R/Shiny resource for predicting Z-DNA forming regions in DNA.

BMC genomics·2025
Same author

Pain in systemic lupus erythematosus: emerging insights and paradigms.

Nature reviews. Rheumatology·2025
Same author

DNA coronas resist nuclease degradation.

Biophysical journal·2025

Related Experiment Video

Updated: Mar 1, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

137.6K

Antinuclear antibody testing - misunderstood or misbegotten?

David S Pisetsky1

  • 1Medical Research Service, Durham Veterans Administration Medical Center, Box 151G, 508 Fulton Street, Durham, North Carolina 27705, USA; and at the Division of Rheumatology and Immunology, Duke University Medical Center, DUMC 3544, Durham, North Carolina 27710, USA.

Nature Reviews. Rheumatology
|May 26, 2017
PubMed
Summary

Antinuclear antibody (ANA) testing is crucial for rheumatic diseases like systemic lupus erythematosus (SLE), but a positive result in healthy individuals complicates diagnosis and research. Further investigation into ANA utility is needed.

More Related Videos

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
10:05

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Published on: January 17, 2018

37.4K
Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis
06:56

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis

Published on: September 26, 2012

11.1K

Related Experiment Videos

Last Updated: Mar 1, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

137.6K
Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
10:05

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Published on: January 17, 2018

37.4K
Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis
06:56

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis

Published on: September 26, 2012

11.1K

Area of Science:

  • Immunology
  • Rheumatology
  • Autoimmunity

Background:

  • Antinuclear antibodies (ANAs) are autoantibodies targeting nuclear components.
  • ANA testing is vital for diagnosing rheumatic diseases, particularly systemic lupus erythematosus (SLE).
  • ANA assays are also used to determine eligibility for SLE clinical trials.

Purpose of the Study:

  • To discuss critical questions surrounding the clinical and research applications of ANA testing.
  • To highlight the complexities and limitations of ANA testing in diagnosis and autoimmunity detection.

Main Methods:

  • Review of current literature and clinical practices regarding ANA testing.
  • Discussion of various ANA assay techniques, including the gold standard fluorescent ANA assay.

Main Results:

  • A positive ANA test is a classification criterion for SLE.
  • 20-30% of the healthy population may test positive for ANA, depending on the assay.
  • ANA expression in SLE may be less common than previously assumed.

Conclusions:

  • The high prevalence of positive ANA tests in healthy individuals complicates their diagnostic utility for SLE.
  • ANA testing's role in detecting preclinical autoimmunity requires further examination.
  • Critical evaluation of ANA testing is essential for both clinical practice and research advancements.